GENOMIC medicine company Lucence Diagnostics unveiled a new blood test to detect cancer and plans to launch a clinical study for a different blood test that can detect multiple cancers early.

TOPLINE

IN the past year since Clearbridge Health was listed on the Singapore Exchange's Catalist board in Dec 2017, the healthcare group has been busy...

IN A BOLD move for venture capital firms in the region, Singapore's Venturecraft has merged with medtech startup Mirxes to form Ark Bio, a cancer detection company armed with a US$40 million...

NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.

NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.

THE BROAD VIEW

GOOGLE China's healthcare industry and the search is likely to toss up articles on topics like the country's shortage of doctors, crowded hospitals and dearth of local clinics. While China...

AN accelerator programme for medical device, digital health and diagnostic startups was launched on Wednesday at the Asia Pacific MedTech Forum.

SINGAPORE medtech startup Advent Access has acquired the global manufacturing and commercialisation rights to the Vwing Vascular Needle Guide product line and other key assets from US vascular...

CATALIST-LISTED startup incubator, Trendlines, has appointed Haim Brosh as its chief financial officer (CFO), joint company secretary and compliance officer, the company announced on Tuesday.  He has...

CATALIST-listed startup incubator Trendlines on Wednesday urged investors to have patience and trust that the market will catch on to the company's business model - even as Trendlines stock,...